Plasma phospho-tau in Alzheimer ’s disease: towards diagnostic and therapeutic trial applications

As the leading cause of dementia, Alzheimer's disease (AD) is a major burden on affected individuals, their families and caregivers, and healthcare systems. Although AD can be identified and diagnosed by cereb...

Source: Molecular Neurodegeneration - March 16, 2023 Category: Neurology Authors: Fernando Gonzalez-Ortiz, Przemys ław R. Kac, Wagner S. Brum, Henrik Zetterberg, Kaj Blennow and Thomas K. Karikari Tags: Review Source Type: research